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ORIGINAL STUDY
Syringocystadenocarcinoma Papilliferum In Situ–Like
Changes in Extramammary Paget Disease:
A Report of 11 Cases
Anastasia M. Konstantinova, MD, PhD,*† Denisa Kacerovska, MD, PhD,‡§ Colin J. R. Stewart, FRCPA,¶
Peter Szepe, MD,k Jan Pitha, MD,**†† Miroslav Sulc, MD,‡‡ Vladimir Bencik, MD,§§
Michal Michal, MD,‡§ Barbara Shideler, MD,** Katrin Kerl, MD,¶¶
and Dmitry V. Kazakov, MD, PhD§¶¶
Abstract: The authors report 11 cases of extramammary Paget
disease (EMPD), all of which also demonstrated a combination of
histological changes highly reminiscent of syringocystadenocarcinoma
papilliferum in situ. In addition to the classical features of EMPD,
characterized by the intraepidermal spread of individually dispersed
neoplastic cells with ample cytoplasm, many of which contained mucin,
there were areas of acanthosis with the substitution of spinous layer
keratinocytes by neoplastic cells, whereas the native basal cell layer was
intact. In addition to acanthosis (and sometimes papillomatosis), the
dermal papillae showed a prominent inﬁltrate of plasma cells,
completing the resemblance to syringocystadenocarcinoma papilliferum
in situ; this similarity was further enhanced in 2 cases, which showed
conspicuous gland formation. One additional case showed multifocal
dermal proliferations compatible with eccrine syringoﬁbroadenoma
(syringoﬁbroadenomatous hyperplasia). The changes described herein
seem to be relatively rare in EMPD, and they can represent a diagnostic
pitfall, as evidenced by 2 cases that were originally misinterpreted as
syringocystadenocarcinoma papilliferum in situ. Clinically, these
microscopic changes sometimes corresponded to nodular lesions, which
were speciﬁcally noted to have a papillated erosive surface.
Key Words: extramammary Paget disease, syringocystadenocarci-
noma papilliferum in situ, acantholysis, acanthosis, vulva, scrotum,
eccrine syringoﬁbroadenoma, anogenital mammary-like glands
(Am J Dermatopathol 2016;38:882–886)
INTRODUCTION
In 1992, Rayne and Santa Cruz1 described 6 cases of
mammary Paget disease typiﬁed by mild epidermal hyperpla-
sia, intraepithelial acantholysis, full thickness epidermal aty-
pia, and marked cytological anaplasia, a histological variant
which they termed anaplastic Paget disease. Similar mam-
mary cases have since been reported, and more recently, Du
et al2 described an identical case of extramammary Paget
disease (EMPD), which the authors likened to an acantholytic
squamous cell carcinoma in situ. Both reports commented on
the importance of recognizing this variant of Paget disease to
avoid misinterpretation.
Other possible diagnostic pitfalls related to benign
epidermal proliferative lesions in EMPD have been described,
and these may be classiﬁed as ﬁbroepithelioma-like changes,
papillomatous hyperplasia, and squamous and psoriasiform
hyperplasia.3,4 In this report, we describe 11 cases of EMPD
with unusual clinical and microscopic appearances. The latter
included acanthosis of the epidermis, its colonization and
substitution by neoplastic cells with an intact basal cell layer,
and dermal papillae ﬁlled with plasma cells, a combination of
features that imitate syrinocystadenocarcinoma papilliferum
in situ.
MATERIALS AND METHODS
The 11 cases constituting the subject of this report were
found among 174 cases lesions of EMPD in joint consultation
and the institutional and personal ﬁles of the authors. Clinical
information and follow-up data were obtained from the
patients’ physicians and/or review of case records. Each case
was stained with hematoxylin and eosin and representative
slides were stained with mucicarmine and immunohistologi-
cally for cytokeratin (CK) 7 and p63.
RESULTS
Clinical Data
The main clinical features of the cases are summarized
in Table 1. There were 7 female and 4 male patients with ages
at the time of the biopsy showing the syringocystadenocarci-
noma papilliferum in situ-like changes ranging from 51 to 89
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years. Locations included vulva (6 cases), scrotum (3 cases),
perianal area (1 case), and mons pubis (1 case). Eight of the
patients presented with a newly diagnosed EMPD, whereas
the other 3 had a previous history of EMPD treated by various
modalities. Clinically, the lesions were characterized by ﬂat
or slightly elevated erythematous or white-gray areas, with
some scaling, excoriations, and crust, but additionally on this
background an exophytic nodule with a papillary surface was
often present. One patient (case 6) had a history of prostate
and colon carcinoma, and another (case 10) had a history of
prostate carcinoma raising the possibility of secondary skin
involvement from these sites. A further patient (case 2) had
a recent history of endometrial endometrioid carcinoma
whereas another (case 8) had invasive carcinoma of the vulva
diagnosed and treated at an outside hospital (histology was
not available for review).
Wide surgical excision was performed in all patients.
Most individuals with available follow-up information had
recurrence of the EMPD requiring further treatment. One
patient (case 10) died of prostate carcinoma 9 years after the
diagnosis of EMPD, and 2 patients (cases 2 and 7) died of
unrelated causes.
Microscopic Features
All cases showed the classical morphology of EMPD
characterized by an intraepidermal spread of individually
distributed cells with ample cytoplasm, in many of which
mucin could be demonstrated histochemically. Cytologically,
the tumor cells were slightly to moderately pleomorphic; in
one case, multinucleated giant cells were also seen. There was
no invasion into the dermis but in all cases, adnexal structures
(hair follicles and/or eccrine ducts) were involved by the
neoplastic process.
In addition, in each case, there was an area of acanthosis
and to lesser degree papillomatosis, with the substitution of the
spinous layer keratinocytes by the Paget cells. However, the
native basal cell layer was intact and encased the centrally
located neoplastic cells. The dermal papillae showed
TABLE 1. Clinical Summary of 11 Patients With EMPD and Syringocystadenocarcinoma Papilliferum In Situ–Like Changes
Case Sex/Age Location Clinical Presentation Treatment Follow-Up
Case 1 F/74 Perianal Flat or slightly elevated erythematous
or white-gray areas
Wide surgical excision Recurrence at 4 yrs
Case 2 F/68 Vulva An exophytic papillated nodule,
clinically suspected ﬁbroma; 8-yr
history of EMPD treated with
vulvectomy and RT; recent history
of endometrial endometrioid
carcinoma
Wide surgical excision Recurrence at 2 yrs; DUC at 4 yrs
Case 3 F/79 Vulva A 2.0-cm papillated superﬁcially
ulcerated nodule on the
background of ﬂat areas; 7-yr
history of EMPD treated with
vulvectomy, LN dissection and
neovulva formation; breast
carcinoma 1 yr previously
Wide surgical excision Recurrence at 5 yrs in neovulva;
NED for 2 yrs
Case 4 F/51 Vulva Three-yr history of EMPD treated by
vulvar resection
Vulvar resection Recurrences at 3, 6–10 yrs.
Case 5 M/69 Groin/scrotum Erythematous area Wide surgical excision NED at 8 mo
Case 6 M/75 Scrotum 3.5 · 2-cm plaque with cobblestone
appearance; history of prostate and
colon cancer
Surgical excision Recent case
Case 7 F/80 Vulva Flat discrete reddened lesion
“discoid” in appearance
Wide surgical excision Recurrence at 4 yrs; second
recurrence at 7 yrs with concurrent
diagnosis of breast carcinoma; no
further treatment for EMPD
(refused by patient); DUC at 5 yrs
Case 8 F/89 Labium major/groin A 6 ·1.5-cm erythematous area on
the right labium majus and two 2 ·
2-cm areas in the right groin; 2-yr
history of invasive (squamous?)
carcinoma of the vulva treated by
surgery and RT
Wide surgical excision Lost to follow up
Case 9 F/83 Vulva Red, thickened excoriated lesion;
initial punch biopsy misinterpreted
as VIN
Wide surgical excision Probable local recurrence at 4 yrs
clinically (not biopsied)
Case 10 M/78 Scrotum Erythematous area; history of prostate
carcinoma
Wide surgical excision No evidence of EMPD; died at 9 yrs
of prostate carcinoma
Case 11 M/88 Mons pubis Erythematous area Wide surgical excision Recent case
LN, lymph node; RT, radiation therapy; NED, no evidence of disease; DUC, dead of unrelated cause; VIN, vulvar intraepithelial neoplasia.
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a prominent inﬁltrate of plasma cells, and thus the overall
appearances were highly reminiscent of syringocystadenocar-
cinoma papilliferum in situ (Fig. 1). The above described
changes were extensive in 8 specimens (cases 1–6, 10, and
11, Table 1) and focal in 3 specimens (cases 7–9). In addition,
in 2 cases, the neoplastic cells focally grew in a dyscohesive
fashion (acantholysis) with focal formation of gland-like struc-
tures and apocrine secretion (Fig. 2). One specimen (сase 6), in
addition to areas resembling syringocystadenocarcinoma pap-
illiferum in situ, showed thin interconnected epithelial strands
in a ﬁbrovascular mucinous stroma, which resembled eccrine
syringoﬁbroadenoma (ESFA) (Fig. 3).
Immunohistochemical Findings
The neoplastic cells expressed CK7 and were negative
for p63. The latter marker stained squamous cells in the
epidermis and demonstrated that the basal cell layer was
mainly preserved, whereas most native keratinocytes had
been replaced by the Paget cells (Fig. 1).
DISCUSSION
The microscopic changes described in this report seem
to be relatively uncommon being identiﬁed in only 11/174
(6.3%) EMPD cases examined by the authors. Although
occasional similar cases have been previously documented,
these have been subject to a different diagnostic interpreta-
tion. Du et al2 described an almost identical case but the
authors felt this most closely resembled an acantholytic squa-
mous cell carcinoma in situ. In our opinion, the changes more
closely mimicked syringocystadenocarcinoma papilliferum in
situ due to the presence of acanthosis, the expansion of the
FIGURE 1. Extramammary Paget
disease with areas resembling sy-
ringocystadenocarcinoma papil-
liferum in situ produced by
epidermal hyperplasia associated
with replacement of native spinous
layer keratinocytes by Paget cells
with only the basal layer being pre-
served. Note stromal papillae filled
with a dense plasma cell–rich infil-
trate (A, C). Staining for CK7 (B).
Staining for p63 highlighting the
preserved basal epithelium sur-
rounding the neoplastic cells (D).
FIGURE 2. Large glandular structures with apocrine secretion
in extramammary Paget disease.
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dermal papillae by plasma cells, and the preservation of the
basal cell layer with encasement of the centrally located neo-
plastic cells thus imitating the basal/myoepithelial cell layers
of that adnexal carcinoma.
Syringocystadenocarcinoma papilliferum is an
extremely rare adnexal neoplasm,5–14 and most lesions arise
from a preexisting syringocystadenoma papilliferum associ-
ated with nevus sebaceus of Jadassohn and as such most
occur in the head and neck. Although cases of syringocysta-
denocarcinoma papilliferum associated with pagetoid intrae-
pithelial spread have been described in the anogenital
region,15,16 in our opinion, the illustrations provided with
these reports suggest that these cases may instead represent
EMPD with a similar phenomenon to that reported herein.
Pagetoid spread of neoplastic cells in syringocystadenocarci-
noma papilliferum in its classical location does occur but this
is rare phenomenon.7,12 The fact that 2 cases in this series
referred in consultation were originally misinterpreted to be
syringocystadenocarcinoma papilliferum indicates that this
change in EMPD is underrecognized and represents a potential
diagnostic pitfall histologically.
In 2 of our patients, the clinical ﬁndings were of
a solitary nodular lesion with an ulcerated papillated surface
on a background of ﬂat or only slightly elevated lesions more
typical of EMPD. Nodules in EMPD are rare, and histological
correlation in such cases suggests that they are caused by an
associated epidermal hyperplasia.17 We posit that these epi-
dermal changes represent a reactive process, most likely re-
sulting from a combined response to direct epidermal
destruction (or cytokine production) by the neoplastic cells,
chronic rubbing by clothes, and/or skin erosion. The latter
might lead to communication with the external environment
and supervening infection, which in turn could sustain the
secondary changes of epidermal hyperplasia and the inﬂux
of plasma cells into the dermal papillae. A similar phenome-
non may be seen in other vulvar lesions18 and also in cuta-
neous adnexal neoplasms, to wit tubular adenomas, which
when acquiring a communication with the outside environ-
ment may develop appearances indistinguishable from syrin-
gocystadenoma papilliferum.19 Lending further support to the
reactive (hyperplastic) nature of the epidermal proliferative
changes was the case in this series that demonstrated areas
resembling ESFA. This lesion is considered by many to be
a benign eccrine neoplasm but an alternative view is that it
represents a reactive process involving the epidermis and
eccrine ducts.20,21 The latter conclusion is supported by the
microscopic heterogeneity of cases reported as ESFA and
their wide clinical associations, including burns,22 erosive
palmoplantar lichen planus,23 bullous pemphigoid,24,25
ulcers of various etiology,26 lymphedema,27 dermatoﬁbroma,28
FIGURE 3. Extramammary Paget
disease with areas resembling
syringocystadenocarcinoma papil-
liferum in situ (A, B) accompanied
by reactive proliferation of unin-
volved eccrine ducts resembling
eccrine syringofibroadenoma and
typified by thin, interconnected
epithelial strands in a fibrovascular
mucinous stroma (C).
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stoma,29,30 podoconiosis,31 amyloidosis,32 and other condi-
tions.33 Some lesions have clearly been induced by irritation
from urine, feces, mechanical friction, or trauma.
In conclusion, morphological changes reminiscent of
syringocystadenocarcinoma papilliferum in situ are occasion-
ally seen in EMPD. The histological changes represent
a potential diagnostic pitfall, and it is essential that these
are recognized to avoid misdiagnosis and mistreatment.
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